A $2.5m National Institutes of Health award will support research [...]

A systematic review of more than two decades of clinical [...]

ViiV Healthcare has received US FDA approval for Tivicay PD [...]

AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]

The FDA has approved ViiV Healthcare’s Tivicay PD for children [...]

A study of 880 men found clinically significant prostate cancer [...]

START and Allegheny Health Network are establishing a new early-phase [...]

Polaryx Therapeutics is preparing to start its Phase 2 SOTERIA [...]

Brainomix will present five studies examining quantitative CT biomarkers in [...]

The FDA has granted Fast Track designation to Erasca’s investigational [...]